Acromegaly:Clinical and Biochemical Features in 500 Patients
Medicine 73:233-240, Ezzat,S.,et al, 1994
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Diagnosis, Treatment, and Outcome of Pituitary Tumors and Other Abnormal Intrasellar Masses, Retrospective Analysis of 353 Patients
Medicine 78:236-269, Gsponer,J.,et al, 1999
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Benign and Malignant Tumors in Patients with Acromegaly
Arch Int Med 151:1629-1632, Barzilay,J.,et al, 1991
Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement
Ophthalmol 96:1038-1047, Patrinely,J.R.,et al, 1989
Treatment of Acromegaly with a Somatostatin Analog in a Patient with McCune-Albright Syndrome
J Pediatr 111:740-743, Geffner,M.E.,et al, 1987
Endocrine Myopathies
BMJ 287:705-708, Kendall-Taylor,P.,et al, 1983